Pfizer (NY: PFE )
36.60 USD +0.08 (+0.22%) Official Closing Price Updated: 7:59 PM EST, Nov 24, 2020 Add to My Watchlist
Stories about Pfizer
Three Events Markets Will Be Watching As 2020 Comes To A Close
Today 17:35 EST
By Scott Bauer Pre-Thanksgiving is typically the time of year when many traders consider paring down positions for the holidays, but ...
Older people, Black and Latinx Americans say they would be hesitant about getting a coronavirus vaccine
Today 15:01 EST
Many Americans say they're hesitant to get a vaccine, even if one was approved by the Food and Drug Administration.
Today 14:49 EST
Tags Stocks / Equities
Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU
Today 13:30 EST
December Outlook: Holidays Arrive For A Wild 2020 As Volatility Eases, Vaccine Hopes Grow
Today 12:37 EST
After the whipsaw year we’ve had, many investors would probably be just fine with a dull December. There are signs they might ...
Celebrate Thanksgiving Week With These ETFs
Today 12:12 EST
Despite the weak forecasts, investors could binge on the Thanksgiving celebration with the following ETFs.
Reinventing Vaccines To Save Lives And The Economy
Today 11:45 EST
Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus ...
General Electric's jet-engine unit warned of more job cuts despite favorable news on Boeing and a coronavirus vaccine.
U.S. is ‘in the middle of the Fight of the Century,’ says former CDC head as cases rise in 45 states, hospitalizations set record
Today 11:04 EST
The U.S. case tally from the coronavirus illness COVID-19 climbed above 12.4 million on Tuesday and hospitalizations again reached record levels, with 45 states reporting rising infections.
Write A Prescription For This Pharma ETF
Today 10:20 EST
After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally ...
Oil futures extend gains Tuesday, a day after the global crude benchmark closed at an eight-month high, as bullish traders cheer progress toward a vaccine.
Pfizer and Moderna are leading the pack, but they're far from being the only companies likely to launch COVID-19 vaccines on the market.
3 Tech Stocks to Buy With COVID-19 Infections Soaring
Today 7:53 EST
The pandemic resulted in investors picking up technology stocks as all other parts of the economy remain at a standstill.
Even when a coronavirus vaccine is ready, distribution could be a challenge -- but recent innovations in medical glass could benefit the public and investors alike.
Dr. Angela Rasmussen explains what investors should know about an under-the-radar coronavirus vaccine developer.
Will Moderna's Coronavirus Vaccine Really Change the Game?
Today 7:40 EST
The trends in the final months of 2020 and moving into 2021 have assembled "The Dream-Team" in saving many lives and the losses in functionalities in those infected with COVID-19 World-Wide Pandemic.
3 Long-Shot Coronavirus Vaccine Stocks to Watch in December
Today 7:03 EST
We sat down with a pandemic expert to find out how the eventual coronavirus vaccines will be similar to and different from the flu shot.
What to Watch for Next in the Coronavirus Vaccine Race
Today 6:37 EST
What Investors Need To Know About Pfizer's Coronavirus Vaccine And Ultra-Cold Storage Requirements
Today 6:31 EST
A doctor and pandemic expert explains how the need to keep vaccine doses ultra-cold may impact distribution.
Should Pfizer Shareholders Sell Their Viatris Stock?
Today 6:05 EST
European markets have maintained yesterday’s momentum with news of easing lockdowns in the UK and France adding to the optimism.
What the Vaccine News Means for Airline Stocks
Today 4:17 EST
Asian equity markets climbed higher during Asia-Pacific trade, after the presidential transition process was triggered by the GSA. The ASX 200 index rose 1.26% while the Nikkei 225 surged 2.5%, on the...
Moderna Inc(NASDAQ: MRNA) Chief Medical Officer Tal Zaks said that the drugmaker’s COVID-19 vaccine would be available for ...
Dr. Fauci on Cuomo’s decision to review vaccines for New Yorkers: ‘Trust the process because it is a sound process’
Today 0:03 EST
The veteran immunologist told a Washington Post video interview: ‘The numbers can be stark, sobering and, in many cases, they can be frightening.’
Is upbeat COVID-vaccine news priced into the market?
November 23, 2020
A growing list of vaccine candidates have rolled out in recent weeks, offering the world a potential exit from a global pandemic nightmare that has claimed some 1.4 million lives in less than a year.